COMPASS Pathways plc

NASDAQ:CMPS

Medical - Care Facilities

Healthcare
$8.12 +0.16%

+$0.02 today

Market cap
$1.15B
Beta
2.51
P/E (TTM)
-7.4
EPS (TTM)
-$1.63
52W Low $2.25High $14.76

Volume 2.35M

Average 4.09M

CMPS Short-term Investments

Marketable securities and deposits the company expects to convert to cash within a year.

COMPASS Pathways plcNASDAQ: CMPS

Short-term Investments · Q1 FY2026 · quarter ended Mar 2026

Short-term investments remains negative

Q1 FY2026 short-term investments was $0, compared with $0 a year earlier.

Context

  • Short-term investments amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Short-term investments increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Short-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Short-term Investments history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Short-term Investments vs competitors

How CMPS compares with its peers on the latest reported figures

  • CMPS's Mar 2026 short-term investments of $0 is the 10th highest of the 11 companies compared; the peer median is $318.94M.
  • Short-term investments amounts to 0.0% of total assets for CMPS, versus a peer median of 36.6%.
CMPS Competitors Peer median
Short-term Investments for CMPS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NERVMinerva Neurosciences, Inc.Jun 2026$50.62B ——53.2%
DFTXDefinium Therapeutics, Inc.Sep 2026$805.7M +326.0%—75.0%
DNLIDenali Therapeutics Inc.Jun 2026$508.94M -32.8%-16.0%44.0%
RAPPRapport Therapeutics, Inc. Common StockMar 2026$398.73M +75.1%—80.1%
PRAXPraxis Precision Medicines, Inc.Sep 2026$383.47M +226.0%+84.0%29.2%
MPLTMapLight Therapeutics, Inc.Mar 2026$254.41M +504.2%—60.7%
HRMYHarmony Biosciences Holdings, Inc.Jun 2026$118.02M +513.9%-34.0%8.6%
LBRXLB Pharmaceuticals Inc Common StockMar 2026$44.96M ——11.4%
GHRSGH Research PLCMar 2026$24.67M -46.8%—9.0%
CMPSCOMPASS Pathways plcMar 2026$0 ——0.0%
ACADACADIA Pharmaceuticals Inc.Sep 2026$0 -100.0%+28.6%0.0%
Peer median (excluding CMPS) $318.94M+150.5%+6.3%36.6%

Competitors are the stored peer set for CMPS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents273.24M143.21M220.2M165.08M149.61M
Short-term Investments00000
Net Receivables11.22M15.62M28.93M21.82M15.39M
Inventory00000
Other Current Assets2.31M1.22M2.34M2.58M5.96M
Total Current Assets295.3M191.65M261.3M201.29M191.49M
Property, Plant & Equipment (Net)4.09M2.62M4.73M2.2M3.42M
Goodwill00000
Intangible Assets00000
Long-term Investments525K469K469K469K10.95M
Tax Assets766K2.22M3.34M3.77M3.75M
Other Non-current Assets213K327K6.16M5.94M734K
Total Non-current Assets5.6M5.64M14.69M12.38M18.86M
Total Assets300.9M197.29M275.99M213.67M210.35M
Account Payables2.56M4.76M5.89M12.28M15.22M
Short-term Debt0005.51M19.63M
Tax Payables593K167K13K00
Deferred Revenue00000
Other Current Liabilities5.29M6.19M8.09M9.24M212.94M
Total Current Liabilities15.11M15.6M19.6M34.02M247.8M
Long-term Debt0028.76M24.65M1.29M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities000014.11M
Total Non-current Liabilities1.38M418K30.64M24.96M15.4M
Total Liabilities16.49M16.01M50.24M58.97M263.2M
Common Stock435K440K635K702K973K
Retained Earnings(169.64M)(261.15M)(379.61M)(534.73M)(822.59M)
Accumulated OCI8.84M(16.87M)(16.93M)(16.19M)(14.79M)
Other Stockholders Equity28K28K000
Minority Interest00000
Total Equity284.41M181.28M225.74M154.7M(52.85M)
Total Debt3.61M1.93M33.05M32.19M20.93M
Net Debt(269.63M)(141.28M)(187.15M)(132.89M)(128.68M)

COMPASS Pathways plc

NASDAQ:CMPS

Intrinsic Alpha fair value

Locked

Current Price

$8.12

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.